We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-7.03%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$446M
AUM Growth
-$188M
Cap. Flow
-$138M
Cap. Flow %
-31.01%
Top 10 Hldgs %
45.39%
Holding
194
New
46
Increased
33
Reduced
32
Closed
61

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$17.1M
2
BABA icon
Alibaba
BABA
+$13.8M
3
JE
Just Energy Group Inc
JE
+$9.47M
4
SMAR
Smartsheet Inc.
SMAR
+$7.86M
5
GH icon
Guardant Health
GH
+$7.05M

Top Sells

Rank Stock Value
1
CTLP
Cantaloupe
CTLP
+$32.7M
2
ELV icon
Elevance Health
ELV
+$26.7M
3
AMD icon
Advanced Micro Devices
AMD
+$7.95M
4
ADBE icon
Adobe
ADBE
+$7.66M
5
XLNX
Xilinx Inc
XLNX
+$7.6M

Sector Composition

Rank Sector Weight
1 Technology 28.57%
2 Industrials 14.77%
3 Healthcare 13.92%
4 Consumer Discretionary 8.46%
5 Utilities 6.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTE
126
CALL
DELISTED
PolarityTE, Inc. Common Stock
PTE
$81K 0.02%
1,000
– –
CGRN
127
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$77K 0.02%
15,000
– –
ABEO icon
128
Abeona Therapeutics
ABEO
$343M
$68K 0.02%
1,200
-400
-25% -$30K
SEEL
129
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$46K 0.01%
13
– –
NVTR
130
DELISTED
Nuvectra Corporation Common Stock
NVTR
$34K 0.01%
25,095
– –
CORV
131
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$25K 0.01%
12,500
– –
ATNM icon
132
Actinium Pharmaceuticals
ATNM
$27.7M
$17K ﹤0.01%
2,500
– –
GE icon
133
GE Aerospace
GE
$371B
$13K ﹤0.01%
301
-602
-67% -$28.3K
ADBE icon
134
Adobe
ADBE
$103B
– –
-26,000
Closed -$7.66M
ADI icon
135
Analog Devices
ADI
$175B
– –
-7,000
Closed -$790K
AMAT icon
136
Applied Materials
AMAT
$362B
– –
-5,000
Closed -$225K
APPN icon
137
Appian
APPN
$2.07B
– –
-7,000
Closed -$252K
ASML icon
138
ASML
ASML
$600B
– –
-1,500
Closed -$311K
BMY icon
139
CALL
Bristol-Myers Squibb
BMY
$130B
– –
-250,000
Closed -$11.3M
BMY icon
140
Bristol-Myers Squibb
BMY
$130B
– –
-8,500
Closed -$385K
BNED icon
141
Barnes & Noble Education
BNED
$443M
– –
-170
Closed -$57K
CCJ icon
142
Cameco
CCJ
$37.1B
– –
-25,000
Closed -$268K
CEVA icon
143
CEVA Inc
CEVA
$872M
– –
-11,000
Closed -$268K
CHRS icon
144
Coherus Oncology
CHRS
$222M
– –
-25,000
Closed -$553K
CQQQ icon
145
Invesco China Technology ETF
CQQQ
$3B
– –
-30,000
Closed -$1.36M
CTLP
146
DELISTED
Cantaloupe
CTLP
– –
-4,400,000
Closed -$32.7M
DQ
147
Daqo New Energy
DQ
$809M
– –
-60,000
Closed -$508K
ELAN icon
148
Elanco Animal Health
ELAN
$12.9B
– –
-13,068
Closed -$442K
ELV icon
149
CALL
Elevance Health
ELV
$83.3B
– –
-70,000
Closed -$19.8M
ELV icon
150
Elevance Health
ELV
$83.3B
– –
-94,500
Closed -$26.7M
4 5
6
7 8

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return

Ardsley Advisory Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Ardsley Advisory Partners held 194 positions worth $446M, down 30% from $634M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Ardsley Advisory Partners withdrew a net $138M in Q3 2019, closing 61 positions and reducing 32 holdings. Its most notable exit was Cantaloupe, an estimated $32.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Ardsley Advisory Partners opened a new position in Alibaba worth $13.4M.

  • Ardsley Advisory Partners's largest Q3 2019 buy was Alibaba: 80,250 shares worth $13.4M.
  • Ardsley Advisory Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019, an estimated $17.1M increase.
  • Ardsley Advisory Partners's biggest Q3 2019 reduction was Advanced Micro Devices, cutting an estimated $7.95M.
  • Ardsley Advisory Partners fully exited Cantaloupe in Q3 2019, selling an estimated $32.7M.
  • Ardsley Advisory Partners's ten largest holdings make up 45% of its $446M portfolio in Q3 2019.
  • Ardsley Advisory Partners opened 46 new positions and closed 61 in Q3 2019.
  • Ardsley Advisory Partners's portfolio value fell 30% quarter-over-quarter to $446M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2019, filed 14 Nov 2019.